Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
This is a phase 3, randomized, placebo controlled, double-blind, multicenter, stratified study of CPI-006 plus standard of care (SOC) versus placebo plus SOC in mild to moderately symptomatic hospitalized Covid-19 patients with the primary objective to compare the proportion of participants alive and respiratory failure free between CPI-006 plus SOC versus placebo plus SOC.
Inclusion Criteria:
Exclusion Criteria:
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
San Miguel de Tucumán, Tucumán Province, Argentina
Vitória, Brazil
Bogotá, Cundinamarca, Colombia
Montería, Departamento de Córdoba, Colombia
Milan, Lombardy, Italy
Busto Arsizio, Italy
Dnipro, Dnipropetrovsk Oblast, Ukraine
Vinnytsia, Vinnytsia Oblast, Ukraine
Lutsk, Volyn Oblast, Ukraine
Zhaporizhzhya, Zaporizhzhia Oblast, Ukraine